These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 27050973)

  • 1. Relationship between the expression of Notch1 and EZH2 and the prognosis of breast invasive ductal carcinoma.
    Zhao L; Zhang QY; Luan X; Huang X; Zhao S; Zhao H
    Genet Mol Res; 2016 Mar; 15(1):. PubMed ID: 27050973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Detection and clinical significance of Notch1 methylation in breast cancer and intraductal proliferative breast lesions].
    Zhang N; Sun ZZ; Li F; Cao YW; Zhao CX; Liang WH; Sun HP; Li HA; Fu XG
    Zhonghua Bing Li Xue Za Zhi; 2011 May; 40(5):324-9. PubMed ID: 21756827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Notch1 mRNA and protein expression in human breast cancer and normal mammary gland tissues].
    Hua BL; Fu XG; Hu WH; Yin L; Kang XL; Li HA; Jiang JF; Li F
    Zhonghua Bing Li Xue Za Zhi; 2009 Dec; 38(12):806-9. PubMed ID: 20193454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melatonin Inhibits Glioblastoma Stem-like cells through Suppression of EZH2-NOTCH1 Signaling Axis.
    Zheng X; Pang B; Gu G; Gao T; Zhang R; Pang Q; Liu Q
    Int J Biol Sci; 2017; 13(2):245-253. PubMed ID: 28255276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study of the role of Notch1 and JAG1 gene methylation in development of breast cancer.
    Sun H; Li K; Shen S
    Med Oncol; 2016 Apr; 33(4):35. PubMed ID: 26971121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implications of the Notch1-Snail/Slug-epithelial to mesenchymal transition axis for lymph node metastasis in infiltrating ductal carcinoma.
    Cao YW; Wan GX; Sun JP; Cui XB; Hu JM; Liang WH; Zheng YQ; Li WQ; Li F
    Kaohsiung J Med Sci; 2015 Feb; 31(2):70-6. PubMed ID: 25645984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EZH2 expands breast stem cells through activation of NOTCH1 signaling.
    Gonzalez ME; Moore HM; Li X; Toy KA; Huang W; Sabel MS; Kidwell KM; Kleer CG
    Proc Natl Acad Sci U S A; 2014 Feb; 111(8):3098-103. PubMed ID: 24516139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NOTCH and EZH2 collaborate to repress PTEN expression in breast cancer.
    Pappas K; Martin TC; Wolfe AL; Nguyen CB; Su T; Jin J; Hibshoosh H; Parsons R
    Commun Biol; 2021 Mar; 4(1):312. PubMed ID: 33750924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of EZH2, paxillin expression and DNA ploidy of breast adenocarcinoma: correlation to pathologic predictors.
    Panousis D; Xepapadakis G; Lagoudianakis E; Karavitis G; Salemis N; Koronakis N; Patsouris E; Koronarchis D; Grosomanidis D; Chryssikos G; Ntasiou P; Kyriakidou V; Athanassiadou AM; Athanassiadou P
    J BUON; 2013; 18(4):879-85. PubMed ID: 24344012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High Notch1 protein expression is an early event in breast cancer development and is associated with the HER-2 molecular subtype.
    Zardawi SJ; Zardawi I; McNeil CM; Millar EK; McLeod D; Morey AL; Crea P; Murphy NC; Pinese M; Lopez-Knowles E; Oakes SR; Ormandy CJ; Qiu MR; Hamilton A; Spillane A; Soon Lee C; Sutherland RL; Musgrove EA; O'Toole SA
    Histopathology; 2010 Feb; 56(3):286-96. PubMed ID: 20459529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of Pofut1 and activated Notch1 may be associated with poor prognosis in breast cancer.
    Wan G; Tian L; Yu Y; Li F; Wang X; Li C; Deng S; Yu X; Cai X; Zuo Z; Cao F
    Biochem Biophys Res Commun; 2017 Sep; 491(1):104-111. PubMed ID: 28709865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subcellular localization of EZH2 phosphorylated at T367 stratifies metaplastic breast carcinoma subtypes.
    McMullen ER; Skala SL; Gonzalez ME; Djomehri S; Chandrashekar DS; Varambally S; Kleer CG
    Breast Cancer; 2021 Mar; 28(2):496-505. PubMed ID: 33247371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancer of zeste homolog 2 (EZH2) expression in bladder cancer.
    Warrick JI; Raman JD; Kaag M; Bruggeman T; Cates J; Clark P; DeGraff DJ
    Urol Oncol; 2016 Jun; 34(6):258.e1-6. PubMed ID: 26976725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant overexpression of EZH2 and H3K27me3 serves as poor prognostic biomarker for esophageal squamous cell carcinoma patients.
    Liu F; Gu L; Cao Y; Fan X; Zhang F; Sang M
    Biomarkers; 2016; 21(1):80-90. PubMed ID: 26631178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of fatty acid synthase and its association with HER2 in invasive ductal carcinoma of breast].
    Yang M; Xu SP; Ao QL
    Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):257-61. PubMed ID: 23928534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancer of zeste homologue 2 expression in breast carcinoma smears in relationship with p53, Ki-67 and other prognostic parameters.
    Athanassiadou AM; Tsipis A; Patsouris E; Gonidi M; Nicolopoulou-Stamati P; Chelidonis G; Athanassiadou P
    Acta Cytol; 2011; 55(2):180-6. PubMed ID: 21325804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of E-cadherin expression and routine immunohistochemistry panel in breast invasive ductal carcinoma.
    Mohammadizadeh F; Ghasemibasir H; Rajabi P; Naimi A; Eftekhari A; Mesbah A
    Cancer Biomark; 2009; 5(1):1-8. PubMed ID: 19242056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant expression of enhancer of zeste homologue 2, correlated with HIF-1α, refines relapse risk and predicts poor outcome for breast cancer.
    Dong M; Fan XJ; Chen ZH; Wang TT; Li X; Chen J; Lin Q; Wen JY; Ma XK; Wei L; Ruan DY; Lin ZX; Liu Q; Wu XY; Wan XB
    Oncol Rep; 2014 Sep; 32(3):1101-7. PubMed ID: 25017254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of Notch1 Correlates with Breast Cancer Progression and Prognosis.
    Yuan X; Zhang M; Wu H; Xu H; Han N; Chu Q; Yu S; Chen Y; Wu K
    PLoS One; 2015; 10(6):e0131689. PubMed ID: 26121683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High expression of EZH2 is associated with tumor aggressiveness and poor prognosis in patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy.
    He LR; Liu MZ; Li BK; Jia WH; Zhang Y; Liao YJ; Chen YC; Zhang LJ; Guan XY; Zeng YX; Kung HF; Xie D
    Int J Cancer; 2010 Jul; 127(1):138-47. PubMed ID: 19904743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.